Latest Breaking News On - Beacon expanded carrier - Page 1 : comparemela.com

Full Year 2023 Total Revenue of $289.2 million; Q4 2023 Total Revenue of $70.5 million Full Year 2023 Core Revenue grows 44% year-over-year to $262.1 million; Q4 2023 Core Revenue grows 21%.

United statesPaul kimMing hsiehFulgent genetics incExchange commissionFulgent geneticsScore revenueChief executive officerPrecision diagnosticsInvestigational new drugChief financial officerInvestor relationsPrivate securities litigation reform actBeacon expanded carrierConsolidated statementTwelve months ended december